Morning Overview on MSN
The Alzheimer’s protein Sox9 works by waking up astrocytes and activating a receptor called MEGF10 that eats amyloid plaques
For decades, Alzheimer’s research has centered on neurons, the brain cells that die as the disease progresses, and on the ...
A major review challenges a long-standing strategy in Alzheimer’s research, suggesting that removing a hallmark brain protein ...
Lactylation, a recently identified post-translational modification, has emerged as important for immune regulation, tissue repair, cancer cell metabolism, and now, potentially, Alzheimer’s disease. In ...
Irvine, Calif., Oct. 23, 2025 — Researchers at the University of California, Irvine, have uncovered an unexpected molecular partnership that reshapes scientists’ understanding of how brain ...
APOE4 comes with a higher risk for Alzheimer's disease, but the 25 per cent of people who have it can lower that risk with ...
Researchers have dosed the first participant in a clinical trial of an investigational medicine designed to lower the amount of amyloid precursor protein (APP) for the potential treatment of Alzheimer ...
– First Patient Dosed in Multiple-dose Part B Portion of Study, with the Study Proceeding in Canada, UK, and the Netherlands – CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Alnylam Pharmaceuticals, Inc. (Nasdaq ...
Previous research has implicated fungi in chronic neurodegenerative conditions such as Alzheimer’s disease, but there is limited understanding of how these common microbes could be involved in the ...
Cerebrospinal fluid (CSF) is a clear and watery liquid that flows in and around the brain and spinal cord. Its functions include protecting parts of the nervous system, delivering nutrients and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results